← FDA Drug Approvals (Drugs@FDA)

GLEEVEC

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 2001-05-10

Drug application

FDA Application #

NDA021335

Application type

New Drug Application

Brand name

GLEEVEC

Generic name

Imatinib Mesylate

Active ingredients

IMATINIB MESYLATE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Discontinued

Sponsor

NOVARTIS

First approval

2001-05-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown